BIVDA Press Releases

27Apr

BIVDA and Diabetes UK call for urgent action on blood glucose monitoring

The British In Vitro Diagnostics Association (BIVDA) and Diabetes UK are calling for healthcare professionals (HCPs) to take urgent action and check their patients’ blood glucose meter systems for compliance ahead of the implementation of ISO Standard 15197: 2013 in May.

To help ensure the accuracy and consistency of results for people with diabetes, revisions have been made to the ISO 15197: 2013 Standard for blood glucose monitoring. The revised standard will come into effect in May and as a result, some meter systems may be rendered non-compliant.

Up to a third of people diagnosed with diabetes are expected to be affected by the changes. As test strips will become unavailable for non-compliant meter systems, it is vital that HCPs check their patients’ meters and if necessary, upgrade them.

BIVDA has provided guidance for HCPs which outlines some of the changes to the revised ISO 15197: 2013 Standard and how to check if a meter system is compliant.

BIVDA’s Chief Executive, Doris-Ann Williams MBE, said: 

“With the implementation deadline rapidly approaching, BIVDA is reminding HCPs to check their patients’ meter systems for compliance. If meter systems are not upgraded, individuals may find themselves unable to monitor their blood glucose as test strips may become unavailable for non-compliant meter systems. 

“We strongly encourage HCPs to read our guidance and take action now to help ensure a smooth transition for patients”.

Simon O’Neill, Director of Health Intelligence and Professional Liaison at Diabetes UK, said:

“For people with diabetes, monitoring their blood glucose levels is key to them managing their condition well."

“It is therefore critical that healthcare professionals make their patients aware of the changes being made to the ISO 15197 Standard for blood glucose monitoring and also check that patients’ meter systems are compliant. If they are not, they must be upgraded. With test strips becoming unavailable for non-compliant meter systems, healthcare professionals must take action now to ensure that all people with diabetes can continue to manage their diabetes well and therefore have the best chance of living long and healthy lives.”

BIVDA’s guidance for HCPs can be viewed here.

Notes to Editor:
BIVDA is the industry association for manufacturers and suppliers of IVD tests. We represent over 100 members, ranging from British start-up companies to UK subsidiaries of multinational corporations. BIVDA member companies employ more than 8,000 people in the UK, with a total industry turnover of approximately £900 million.

For further information, please contact External Affairs Manager Emma Thomas at emma@bivda.co.uk or 0845 6188224.

Related

BIVDA’s Response to the 2017 General Election Result

Commenting on the result of the Election, BIVDA’s Chief Executive Doris-Ann Williams MBE said: “...

Read More >

BIVDA Launches IVD Value Story

The British In Vitro Diagnostics Association (BIVDA) has today (25 October) launched its new report ...

Read More >

BIVDA Response to 2017 Budget

The Chancellor of the Exchequer has today (22 November) delivered the Government’s 2017 Budget.

Read More >

BIVDA Response to Cancer Research UK Report on Pathology Services

Cancer Research UK have today (23 November 2016) published a report which finds that UK pathology se...

Read More >

BIVDA Celebrates Milestone 25th Anniversary

The British In Vitro Diagnostics Association (BIVDA) celebrated its milestone 25th Anniversary on Mo...

Read More >

BIVDA Attends UN Meeting on Antimicrobial Resistance

Doris-Ann Williams MBE, Chief Executive of the British In Vitro Diagnostics Association (BIVDA), rep...

Read More >